Wednesday, July 8, 2026

pharma · Type 2 Diabetes Mellitus · Irritable Bowel Syndrome · LXRX

LEXICON PHARMACEUTICALS

Lexicon Pharmaceuticals is a pharma organization headquartered in The Woodlands, USA. It trades on NYSE under ticker LXRX. Primary therapeutic focus areas include Type 2 Diabetes Mellitus, Irritable Bowel Syndrome, Rheum

8800 Technology Forest, The Woodlands, TX 77381, US HQ
1995 Founded
282 Employees
Public company Type
LXRX · NYSE Ticker
Company details
Status
Public
HQ
8800 Technology Forest, The Woodlands, TX 77381, US
Founded
1995
Employees
282
Programs
51
Drugs
27
Patents
102
Clinical program

Treatment A digoxin

Phase 1 · small molecule · Healthy

Treatment A digoxin for Healthy is a Phase 1 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

← All LEXICON PHARMACEUTICALS, INC. projects Phase 1 small molecule completed

Internal code LX4211.1-114-NRM

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
LEXICON PHARMACEUTICALS, INC.
Phase
Phase 1
Modality
small_molecule
Indication
Healthy
Status
completed
Trials
1